• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ATH 0.00% 0.6¢

ALTERITY THERAPEUTICS LIMITED

Alterity Therapeutics Limited is an Australia-based clinical-stage biotechnology company.... Alterity Therapeutics Limited is an Australia-based clinical-stage biotechnology company. The Company is focused on developing disease modifying treatments for neurodegenerative diseases. The Company’s lead asset, ATH434, is to treat various Parkinsonian disorders. ATH434 is an oral agent designed to inhibit the aggregation of pathological proteins implicated in neurodegeneration. It has the potential to treat Parkinson’s disease, as well as various Parkinsonian disorders, such as Multiple System Atrophy (MSA). The Company also has a drug discovery platform generating patentable chemical compounds to intercede in disease processes. ATH434 has been granted Orphan designation for the treatment of MSA. The Phase 2 clinical trial is a randomized, double-blind, placebo-controlled investigation of ATH434 in patients with early-stage MSA.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
ATH
Orphan drug week - 22nd to 26th April
25/04/24 11 2.2K
25/04/24 Last post  tuts Comments Created with Sketch.  11  Views Created with Sketch.  2.2K 
ATH
Alpha-synuclein induced synucleinopathies and NBIA's
23/04/24 6 1.9K
23/04/24 Last post  brryh Comments Created with Sketch.  6  Views Created with Sketch.  1.9K 
ATH
Stanford scientists: iron-calcium in mitochondrion as target in PD treatment
22/04/24 10 4.2K
22/04/24 Last post  pivalde Comments Created with Sketch.  10  Views Created with Sketch.  4.2K 
ATH 19/04/24 22 5.4K
19/04/24 Last post  Scottsmyname Comments Created with Sketch.  22  Views Created with Sketch.  5.4K 
ATH
Week ahead - 15th April - 19th April
19/04/24 31 8.8K
19/04/24 Last post  Scottsmyname Comments Created with Sketch.  31  Views Created with Sketch.  8.8K 
ATH 18/04/24 1 434
18/04/24 Last post  Scottsmyname Comments Created with Sketch.  1  Views Created with Sketch.  434 
ATH
another good day in New York
15/04/24 24 6.1K
15/04/24 Last post  Scottsmyname Comments Created with Sketch.  24  Views Created with Sketch.  6.1K 
ATH 15/04/24 1 496
15/04/24 Last post  rakeshnirzari1 Comments Created with Sketch.  1  Views Created with Sketch.  496 

See All Discussions arrow Created with Sketch.

Timeline

Change in substantial holding
18 Apr 08:24
 
Alterity Parkinson's and MSA Data Featured at AAN Meeting
17 Apr 08:48
 
Application for quotation of securities - ATH
15 Apr 10:40
 
Options Prospectus
12 Apr 11:30
 
Results of Extraordinary General Meeting
12 Apr 10:47
 
Alterity to Present New ATH434 Data at Orphan Drug Congress
10 Apr 08:35
 
View More arrow Created with Sketch.
(20min delay)
Last
0.6¢
Change
0.000(0.00%)
Mkt cap ! $31.42M
Open High Low Value Volume
0.6¢ 0.6¢ 0.6¢ $167.7K 28.03M

Buyers (Bids)

No. Vol. Price($)
51 60438660 0.5¢
 

Sellers (Offers)

Price($) Vol. No.
0.6¢ 1000000 1
View Market Depth
Last trade - 16.10pm 25/04/2024 (20 minute delay) ?
Last
0.6¢
  Change
0.000 ( 0.00 %)
Open High Low Volume
0.6¢ 0.6¢ 0.6¢ 11150927
Last updated 15.56pm 25/04/2024 ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.